Phased variants improve DLBCL minimal residual disease detection at the end of therapy - Kurtz, David Matthew; Chabon, Jacob J.; Soo, Joanne; Co Ting Keh, Lyron; Alig, Stefan; Schultz, Andre; Jin, Michael C.; Scherer, Florian; Craig, Alexander F.M.; Liu, Chih Long; Duehrsen, Ulrich; Huettmann, Andreas; et al. (Journal of clinical oncology, 2021)